Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Microchips
Product Overview
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Subdermal
Duration Type:
Long-acting
Description:
A contraceptive microchip that is implanted under the skin and continuously releases a progestin for as long as 16 years. It is also programmable such that the release of progestin can be turned on and off by the user or provider.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
levonorgestrel
Potential Multi-Purpose Technology (MPT):
No
Regimen:
Daily release
Duration:
16 years
Dose:
30 mcg
Partner:
Microchips Biotech, Inc.
Status
Project Phase:
Discovery
Project Stage:
Target ID/Validation
Began discovery in:
2013
Status Details:
Microchips is also developing their technology for other therapeutic areas.
Programmatic Considerations
Additional Information
Additional Information:
Microchips website
Download Product Report
